Free Trial
NASDAQ:MMSI

Merit Medical Systems (MMSI) Stock Price, News & Analysis

Merit Medical Systems logo
$86.63 -0.06 (-0.07%)
Closing price 11/13/2026 04:00 PM Eastern
Extended Trading
$86.60 -0.02 (-0.03%)
As of 11/13/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Merit Medical Systems Stock (NASDAQ:MMSI)

Advanced

Key Stats

Today's Range
$85.97
▼
$87.37
50-Day Range
$84.16
▼
$94.20
52-Week Range
$59.74
▼
$94.85
Volume
421,763 shs
Average Volume
773,623 shs
Market Capitalization
$5.19 billion
P/E Ratio
32.57
Dividend Yield
N/A
Price Target
$105.55
Consensus Rating
Moderate Buy

Company Overview

Merit Medical Systems develops, manufactures and markets medical devices used in diagnostic and interventional procedures. Its products support clinicians in areas including cardiology, radiology, oncology and endoscopy.

The company’s portfolio includes devices and accessories for vascular access, diagnostic and therapeutic procedures, drainage, biopsy and embolization. Merit serves hospitals, clinics and other healthcare providers through direct sales and distribution channels.

Founded in 1987 and headquartered in South Jordan, Utah, Merit Medical serves customers in the United States and internationally. Its products are used in healthcare markets around the world.

AI Generated. May Contain Errors.

Merit Medical Systems Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
72nd Percentile Overall Score

MMSI MarketRank™: 
3.59955374721 of 5 stars

Merit Medical Systems scored higher than 72% of companies evaluated by MarketBeat, and ranked 200th out of 893 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Merit Medical Systems has received a consensus rating of Moderate Buy. The company's average rating score is 2.62, and is based on no strong buy ratings, 8 buy ratings, 5 hold ratings, and no sell ratings.

  • Upside Potential

    Merit Medical Systems has a consensus price target of $105.55, representing about 21.8% upside from its current price of $86.63.

  • Amount of Analyst Coverage

    Merit Medical Systems has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Merit Medical Systems' stock forecast and price target.
  • Earnings Growth

    Earnings for Merit Medical Systems are expected to grow by 9.07% in the coming year, from $3.86 to $4.21 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Merit Medical Systems is 32.57, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.40.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Merit Medical Systems is 32.57, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.56.

  • Price to Earnings Growth Ratio

    Merit Medical Systems has a PEG Ratio of 2.11. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Merit Medical Systems has a P/B Ratio of 2.97. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    6.72% of the float of Merit Medical Systems has been sold short.
  • Short Interest Ratio / Days to Cover

    Merit Medical Systems has a short interest ratio ("days to cover") of 5.11.
  • Change versus previous month

    Short interest in Merit Medical Systems has recently increased by 5.35%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Merit Medical Systems does not currently pay a dividend.

  • Dividend Growth

    Merit Medical Systems does not have a long track record of dividend growth.

  • News Sentiment

    Merit Medical Systems has a news sentiment score of 0.96. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.60 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Merit Medical Systems this week, compared to 4 articles on an average week.
  • Search Interest

    3 people have searched for MMSI on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Merit Medical Systems to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Merit Medical Systems insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    0.70% of the stock of Merit Medical Systems is held by insiders.

  • Percentage Held by Institutions

    99.66% of the stock of Merit Medical Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Merit Medical Systems' insider trading history.
Receive MMSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Merit Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MMSI Stock News Headlines

Today's free pick (on me)
Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one lesser known company. With plans filed for 1,000,000 new satellites, that licensing fee could scale dramatically. Analyst Dylan says the stock could move by December 8th.tc pixel
See More Headlines

MMSI Stock Analysis - Frequently Asked Questions

Merit Medical Systems' stock was trading at $88.14 at the beginning of the year. Since then, MMSI shares have decreased by 1.7% and is now trading at $86.63.

Merit Medical Systems, Inc. (NASDAQ:MMSI) posted its earnings results on Thursday, October, 29th. The medical instruments supplier reported $1.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.04 by $0.08. The company's revenue was up 8.4% on a year-over-year basis.
Read the conference call transcript
.

Merit Medical Systems subsidiaries include these companies: Fibrovein Holdings Limited, Brightwater Medical Inc., Vascular Insights LLC, Cianna Medical Inc., DFINE Inc., BioSphere Medical SA, Alveolus Inc., and others.

Top institutional investors of Merit Medical Systems include Conestoga Capital Advisors LLC (2.53%), Congress Asset Management Co. (2.11%), William Blair Investment Management LLC (1.87%) and Boston Trust Walden Corp (0.89%). Insiders that own company stock include Fred P Lampropoulos, Joseph Wright, F Ann Millner, Raul Jr Parra, Thomas James Gunderson, Neil Peterson, Lynne N Ward, David Floyd, Stephen C Evans and Brian G Lloyd.
View institutional ownership trends
.

Shares of MMSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Merit Medical Systems investors own include NVIDIA (NVDA), Netflix (NFLX), Walt Disney (DIS), AT&T (T), International Business Machines (IBM), Merck & Co., Inc. (MRK) and Micron Technology (MU).

Company Calendar

Last Earnings
10/29/2026
Today
11/15/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Supplies
Current Symbol
NASDAQ:MMSI
CIK
856982
Employees
7,500
Year Founded
1987

Price Target and Rating

High Price Target
$121.00
Low Price Target
$92.00
Potential Upside/Downside
+21.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.62
Research Coverage
13 Analysts

Profitability

EPS (Trailing Twelve Months)
$2.66
Trailing P/E Ratio
32.57
Forward P/E Ratio
20.58
P/E Growth
2.11
Net Income
$128.49 million
Net Margins
9.94%
Pretax Margin
13.14%
Return on Equity
14.12%
Return on Assets
8.37%

Debt

Debt-to-Equity Ratio
0.42
Current Ratio
4.52
Quick Ratio
3.05

Sales & Book Value

Annual Sales
$1.61 billion
Price / Sales
3.22
Cash Flow
$5.87 per share
Price / Cash Flow
14.75
Book Value
$29.12 per share
Price / Book
2.97

Miscellaneous

Outstanding Shares
59,915,000
Free Float
59,496,000
Market Cap
$5.19 billion
Optionable
Optionable
Beta
0.56

Social Links

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

This page (NASDAQ:MMSI) was last updated on 11/13/2026 by MarketBeat.com Staff.
From Our Partners